nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bioequivalence comparison of two formulations of rifampicin (300- vs 150-mg capsules): An open-label, randomized, two-treatment, two-way crossover study in healthy volunteers
|
Chik, Zamri |
|
2010 |
32 |
10 |
p. 1822-1831 10 p. |
artikel |
2 |
Acute hepatitis associated with the use of levofloxacin
|
Figueira-Coelho, João |
|
2010 |
32 |
10 |
p. 1733-1737 5 p. |
artikel |
3 |
Allergic shock and death associated with protamine administration in a diabetic patient
|
Chu, Yan-Qi |
|
2010 |
32 |
10 |
p. 1729-1732 4 p. |
artikel |
4 |
Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers
|
Stockis, Armel |
|
2010 |
32 |
10 |
p. 1813-1821 9 p. |
artikel |
5 |
Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary report
|
Chen, Mei-Ling |
|
2010 |
32 |
10 |
p. 1704-1712 9 p. |
artikel |
6 |
Comparative resource utilization in medicaid-eligible patients with asthma treated with fixed-dose fluticasone propionate/salmeterol or fluticasone propionate monotherapy
|
Stanford, Richard H. |
|
2010 |
32 |
10 |
p. 1782-1793 12 p. |
artikel |
7 |
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study
|
Crank, Christopher W. |
|
2010 |
32 |
10 |
p. 1713-1719 7 p. |
artikel |
8 |
Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain
|
Kwong, W. Jacqueline |
|
2010 |
32 |
10 |
p. 1768-1781 14 p. |
artikel |
9 |
Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants
|
Gouyon, Jean-Bernard |
|
2010 |
32 |
10 |
p. 1740-1748 9 p. |
artikel |
10 |
Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor
|
Boyce, Eric G. |
|
2010 |
32 |
10 |
p. 1681-1703 23 p. |
artikel |
11 |
Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study
|
Tousoulis, Dimitris |
|
2010 |
32 |
10 |
p. 1720-1728 9 p. |
artikel |
12 |
Perspectives on the bioequivalence and therapeutic equivalence of generic formulations: An overview of the landscape
|
Perry, Richard |
|
2010 |
32 |
10 |
p. 1796-1797 2 p. |
artikel |
13 |
Pharmacokinetics and safety of aclidinium bromide, a muscarinic antagonist, in adults with normal or impaired renal function: A phase I, open-label, single-dose clinical trial
|
Schmid, Karin |
|
2010 |
32 |
10 |
p. 1798-1812 15 p. |
artikel |
14 |
Pharmacokinetics and tolerability of intravenous cefotetan disodium for injection in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study
|
Shi, Shaojun |
|
2010 |
32 |
10 |
p. 1832-1841 10 p. |
artikel |
15 |
Relative bioavailability and pharmacokinetic comparison of two 2-mg risperidone tablet formulations: A single dose, randomized-sequence, double-blind, 2-way crossover study in healthy male volunteers in thailand
|
Boonleang, Jutima |
|
2010 |
32 |
10 |
p. 1842-1853 12 p. |
artikel |
16 |
Results of a model analysis of the cost-effectiveness of liraglutide versus exenatide added to metformin, glimepiride, or both for the treatment of type 2 diabetes in the United States
|
Lee, Won Chan |
|
2010 |
32 |
10 |
p. 1756-1767 12 p. |
artikel |
17 |
Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists
|
Miller, Bradley S. |
|
2010 |
32 |
10 |
p. 1749-1751 3 p. |
artikel |
18 |
Systematic reviews: When the published literature is the data
|
Lyles, Alan |
|
2010 |
32 |
10 |
p. 1754-1755 2 p. |
artikel |